Literature DB >> 28737569

Elevated Hemoglobin Level Is Associated With Advanced Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease.

Valentina Giorgio1, Antonella Mosca, Arianna Alterio, Anna Alisi, Antonio Grieco, Valerio Nobili, Luca Miele.   

Abstract

OBJECTIVES: Hemoglobin (Hb) and red blood cell distribution width (RDW) have been reported to be a risk marker of metabolic syndrome and nonalcoholic fatty liver disease (NAFLD). No study exists on pediatric populations. We aimed to determine the association between hematological parameters, and the severity of disease in children with biopsy-proven NAFLD.
METHODS: A total of 117 children (85 boys, mean age 12 years) with ultrasound evidence of NAFLD undergoing liver biopsy for diagnosis of nonalcoholic steatohepatitis (NASH), were prospectively enrolled between January 2011 and May 2013 in the setting of a tertiary care center. Children were screened for routine hematological and metabolic parameters, and causes of liver steatosis other than nonalcoholic were excluded, before liver biopsy was performed.
RESULTS: A total of 41 NAFLD (boys 29, mean age 11.2 years) and 76 NASH (boys 56, mean age 12.8 years) children were studied. Alanine transaminase levels were significantly higher in NASH group compared with NAFLD group (P = 0.05), and homeostatic model assessment of insulin resistance and triglycerides levels (P = 0.03 and 0.02, respectively). Regarding hematological components: red cell count, Hb, hematocrit, and RDW values were all significantly higher in NASH group compared with NAFLD group (P < 0.05 for each parameter).
CONCLUSIONS: Children with NASH were more likely to have high levels of RDW compared to those with steatosis only. Moreover, NASH was associated with higher red cell count, Hb, and hematocrit. If confirmed in future follow-up studies, hematological parameters may be introduced in algorithms for NASH risk prediction.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28737569     DOI: 10.1097/MPG.0000000000001614

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  6 in total

1.  Nonalcoholic fatty liver disease in obese adolescent females is associated with multi-tissue insulin resistance and visceral adiposity markers.

Authors:  Melanie Cree-Green; Sonalee Ravi; Anne-Marie Carreau; Rachel Sewell; Amy Baumgartner; Gregory Coe; Bryan C Bergman; Ann Scherzinger; Thomas Jensen; Laura Pyle; Kristen J Nadeau
Journal:  Metabol Open       Date:  2019-06-08

2.  A predictive model for the diagnosis of non-alcoholic fatty liver disease based on an integrated machine learning method.

Authors:  Xuefeng Ma; Chao Yang; Kun Liang; Baokai Sun; Wenwen Jin; Lizhen Chen; Mengzhen Dong; Shousheng Liu; Yongning Xin; Likun Zhuang
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

3.  Relationship of Red Blood Cell Distribution Width with Cancer Mortality in Hospital.

Authors:  Jinmeng Li; Xiaoning Yang; Junfeng Ma; Fanghua Gong; Qiongzhen Chen
Journal:  Biomed Res Int       Date:  2018-11-14       Impact factor: 3.411

4.  Integrative analysis of blood and gut microbiota data suggests a non-alcoholic fatty liver disease (NAFLD)-related disorder in French SLAdd minipigs.

Authors:  Marco Moroldo; Peris Mumbi Munyaka; Jérôme Lecardonnel; Gaëtan Lemonnier; Eric Venturi; Claire Chevaleyre; Isabelle P Oswald; Jordi Estellé; Claire Rogel-Gaillard
Journal:  Sci Rep       Date:  2020-01-14       Impact factor: 4.379

5.  Influence of benzene exposure, fat content, and their interactions on erythroid-related hematologic parameters in petrochemical workers: a cross-sectional study.

Authors:  Xue Zhang; Qifei Deng; Zhini He; Jie Li; Xiaoju Ma; Zhaorui Zhang; Dehua Wu; Xiumei Xing; Jing Peng; Hongyu Guo; Ming Huang; Liping Chen; Shanfeng Dang; Yanqun Zhu; Zhengbao Zhang; Boyi Yang; Hailan Wang; Wen Chen; Yongmei Xiao
Journal:  BMC Public Health       Date:  2020-03-23       Impact factor: 3.295

6.  Red Blood Cell Count: An Unrecognized Risk Factor for Nonalcoholic Fatty Liver Disease.

Authors:  Fang Zhong; Liying Guan; Haiyan Lin; Meng Zhao; Yiming Qin; Qihang Li; Zhongshang Yuan; Guang Yang; Ling Gao; Jiajun Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-07       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.